Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.
/health-product-policy-and-standards-(hps)/63022.jpg?sfvrsn=e93c78d1_9 "Ministry of Health staff at their office in Port Vila")
/health-product-policy-and-standards-(hps)/who_034416-sm.jpg?sfvrsn=fc08f9ca_4 "WHO_034416 sm")
/health-product-policy-and-standards-(hps)/70820.jpg?sfvrsn=6b0fda4c_1 "70820")
Expert Committees
Advisory groups
Databases
Publications
All →
12 November 2025
Development of medical device policies, 2nd ed.
A first edition of the Development of Medical Devices Policies was published in 2011. This second edition was prepared to reflect the transition from the...
6 October 2025
Improving access to assistive technology in United Republic of Tanzania (2022-2023): project report
The report summarizes a collaboration between the Ministry of Health of the United Republic of Tanzania, HelpAge Tanzania and the World Health Organization...
5 October 2025
Enabling rapid access to essential assistive technology in Ukraine (2022-2023): project report
This report summarizes a collaboration between the Ministry of Health of Ukraine and the World Health Organization (WHO) in 2022 and 2023. The goal was...
3 October 2025
WHO Drug Information - Volume 39, No. 3
The Third issue of volume 39 for 2025 includes:Consultation Documents: Cefiderocol sulfate tosilate (cefiderocoli sulfas tosilatum) Cefiderocol powder...
Journal articles
WHO implementation workshop on guidelines on procedures and data requirements for changes to approved biotherapeutic products: Seoul, Republic of Korea, 25–26 June 2019
Biologicals Volume 65, May 2020, Pages 50-59
WHO informal consultation on development of guidelines on procedures and data requirements for changes to approved biotherapeutic products: Seoul, Republic of Korea, 27–28 April 2017
Biologicals, Volume 52, March 2018, Pages 83-91
1st WHO International Standard antiserum to RSV: Availability and benefits for RSV vaccine development: Commentary on the collaborative study report published in the vaccine journal (Vaccine 2018 36: 7641-7649)
Vaccine, 2019 Jul 18; 37(31):4233-4235
